Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

In-hospital delays to stroke thrombolysis: paradoxical effect of early arrival.

Romano JG, Muller N, Merino JG, Forteza AM, Koch S, Rabinstein AA.

Neurol Res. 2007 Oct;29(7):664-6. doi: 10.1179/016164107X240035.

PMID:
18173904
2.

Why are eligible thrombolysis candidates left untreated?

Hills NK, Johnston SC.

Am J Prev Med. 2006 Dec;31(6 Suppl 2):S210-6.

PMID:
17178305
3.

Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.

Sauser K, Levine DA, Nickles AV, Reeves MJ.

JAMA Neurol. 2014 Sep;71(9):1155-61. doi: 10.1001/jamaneurol.2014.1528.

PMID:
25023407
4.

Bigger, faster? Associations between hospital thrombolysis volume and speed of thrombolysis administration in acute ischemic stroke.

Bray BD, Campbell J, Cloud GC, Hoffman A, Tyrrell PJ, Wolfe CD, Rudd AG; Intercollegiate Stroke Working Party Group..

Stroke. 2013 Nov;44(11):3129-35. doi: 10.1161/STROKEAHA.113.001981. Erratum in: Stroke. 2013 Nov;44(11):162.

5.

Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program.

Rost NS, Smith EE, Pervez MA, Mello P, Dreyer P, Schwamm LH.

Circ Cardiovasc Qual Outcomes. 2012 May;5(3):314-20. doi: 10.1161/CIRCOUTCOMES.111.962829.

6.

Reducing in-hospital delay to 20 minutes in stroke thrombolysis.

Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M.

Neurology. 2012 Jul 24;79(4):306-13. doi: 10.1212/WNL.0b013e31825d6011.

PMID:
22622858
7.

Multimodal imaging does not delay intravenous thrombolytic therapy in acute stroke.

Salottolo KM, Fanale CV, Leonard KA, Frei DF, Bar-Or D.

AJNR Am J Neuroradiol. 2011 May;32(5):864-8. doi: 10.3174/ajnr.A2394.

8.

Prehospital triage to primary stroke centers and rate of stroke thrombolysis.

Prabhakaran S, O'Neill K, Stein-Spencer L, Walter J, Alberts MJ.

JAMA Neurol. 2013 Sep 1;70(9):1126-32. doi: 10.1001/jamaneurol.2013.293.

PMID:
23817961
9.
10.

Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.

Schwamm LH, Ali SF, Reeves MJ, Smith EE, Saver JL, Messe S, Bhatt DL, Grau-Sepulveda MV, Peterson ED, Fonarow GC.

Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):543-9. doi: 10.1161/CIRCOUTCOMES.111.000303.

11.

Distance from home to hospital and thrombolytic utilization for acute ischemic stroke.

Acharya AB, Nyirenda JC, Higgs GB, Bloomfield MS, Cruz-Flores S, Connor LT, Lee JM, Leet TL.

J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4):295-301. doi: 10.1016/j.jstrokecerebrovasdis.2009.12.009.

PMID:
20634096
12.

Drill down analysis of door-to-needle time of acute ischemic stroke patients treated with intravenous tissue plasminogen activator.

Schrock JW, Lum M.

Am J Emerg Med. 2014 Nov;32(11):1330-3. doi: 10.1016/j.ajem.2014.08.002.

PMID:
25195044
13.

Hospital arrival time and intravenous t-PA use in US Academic Medical Centers, 2001-2004.

Lichtman JH, Watanabe E, Allen NB, Jones SB, Dostal J, Goldstein LB.

Stroke. 2009 Dec;40(12):3845-50. doi: 10.1161/STROKEAHA.109.562660.

14.

Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital.

Szoeke CE, Parsons MW, Butcher KS, Baird TA, Mitchell PJ, Fox SE, Davis SM.

Med J Aust. 2003 Apr 7;178(7):324-8.

PMID:
12670274
15.

Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.

Lin CB, Peterson ED, Smith EE, Saver JL, Liang L, Xian Y, Olson DM, Shah BR, Hernandez AF, Schwamm LH, Fonarow GC.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):514-22. doi: 10.1161/CIRCOUTCOMES.112.965210.

16.

Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1.

Lambrew CT, Bowlby LJ, Rogers WJ, Chandra NC, Weaver WD.

Arch Intern Med. 1997 Dec 8-22;157(22):2577-82.

PMID:
9531226
17.

Does study enrollment delay treatment with intravenous thrombolytics for acute ischemic stroke?

Martin-Schild S, Albright KC, Hallevi H, Barreto AD, Grotta JC, Savitz SI.

Stroke. 2009 Feb;40(2):663. doi: 10.1161/STROKEAHA.108.525352.

18.

Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator.

Abdullah AR, Smith EE, Biddinger PD, Kalenderian D, Schwamm LH.

Prehosp Emerg Care. 2008 Oct-Dec;12(4):426-31. doi: 10.1080/10903120802290828.

PMID:
18924004
19.

Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.

Mathews MS, Sharma J, Snyder KV, Natarajan SK, Siddiqui AH, Hopkins LN, Levy EI.

Neurosurgery. 2009 Nov;65(5):860-5; discussion 865. doi: 10.1227/01.NEU.0000358953.19069.E5.

PMID:
19834397
20.

Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.

Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.

J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016.

PMID:
21968092

Supplemental Content

Support Center